Header Logo

Connection

DOV KADMON to T-Lymphocytes, Cytotoxic

Back to Details
This is a "connection" page, showing publications DOV KADMON has written about T-Lymphocytes, Cytotoxic.
DOV KADMON
Connection Strength
0.013
T-Lymphocytes, Cytotoxic
  1. IL-12 gene-modified bone marrow cell therapy suppresses the development of experimental metastatic prostate cancer. Cancer Gene Ther. 2007 Oct; 14(10):819-27.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.